Concepedia

Randomized controlled trial of perhexiline on regression of left ventricular hypertrophy in patients with symptomatic hypertrophic cardiomyopathy (RESOLVE-HCM trial)

Rajiv Ananthakrishna, Sau L. Lee, Jonathon Foote, Benedetta C. Sallustio, G Binda, Arduino A. Mangoni, Richard Woodman, Christopher Semsarian, John D. Horowitz, Joseph B. Selvanayagam

American Heart Journal · 2021 · 25 citations · 31 references

DOI

Concepts

References

31

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

Stefano Nistri · European Heart Journal · 2014 · 4.3K citations · Full text

, , +13

Sudden Death in Young Competitive Athletes

Barry J. Maron · JAMA · 1996 · 1.7K citations

, , +10

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.2K citations · Full text

, , +6

Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model

Luciano C. Amado, Bernhard Gerber, Sandeep Gupta et al. · Journal of the American College of Cardiology · 2004 · 503 citations

, , +16

Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy

Jenifer Crilley, Ernest Boehm, Edward Blair et al. · Journal of the American College of Cardiology · 2003 · 433 citations

, , +12